| 1. Ojasoo T, Doré JC, Gilbert J, Raynaud JP.. (1988) Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis., 31 (6): [PMID:2897467] [10.1021/jm00401a015] |
| 2. Maitrejean M, Comte G, Barron D, El Kirat K, Conseil G, Di Pietro A.. (2000) The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein., 10 (2): [PMID:10673101] [10.1016/s0960-894x(99)00636-8] |
| 3. Hamann LG, Farmer LJ, Johnson MG, Bender SL, Mais DE, Wang MW, Crombie D, Goldman ME, Jones TK.. (1996) Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether., 39 (9): [PMID:8627601] [10.1021/jm950747d] |
| 4. Zhong-Qi Wang, Shou-Fu Lu, Lin Chao, Chuan-Jun Yang. (1995) An efficient synthesis and biological activities of 19-nor-17-hydroxy-17-trifluoromethyl-4-estren-3-one and its analogs, 5 (17): [10.1016/0960-894X(95)00320-S] |
| 5. Zhi L, Tegley CM, Pio B, Edwards JP, Jones TK, Marschke KB, Mais DE, Risek B, Schrader WT.. (2003) Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators., 13 (12): [PMID:12781197] [10.1016/s0960-894x(03)00255-5] |
| 6. Zhi L, Ringgenberg JD, Edwards JP, Tegley CM, West SJ, Pio B, Motamedi M, Jones TK, Marschke KB, Mais DE, Schrader WT.. (2003) Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore., 13 (12): [PMID:12781198] [10.1016/s0960-894x(03)00256-7] |
| 7. Akritopoulou-Zanze I, Patel JR, Hartandi K, Brenneman J, Winn M, Pratt JK, Grynfarb M, Goos-Nisson A, Von Geldern TW, Kym PR.. (2004) Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists., 14 (9): [PMID:15080982] [10.1016/j.bmcl.2004.02.048] |
| 8. Collins MA, Hudak V, Bender R, Fensome A, Zhang P, Miller L, Winneker RC, Zhang Z, Zhu Y, Cohen J, Unwalla RJ, Wrobel J.. (2004) Novel pyrrole-containing progesterone receptor modulators., 14 (9): [PMID:15081005] [10.1016/j.bmcl.2004.02.054] |
| 9. Gebhard R, van der Voort H, Schuts W, Schoonen W. (1997) 11,21-Bisphenyl-19-norpregnane derivatives are selective antiglucocorticoids, 7 (17): [10.1016/S0960-894X(97)00397-1] |
| 10. Sorensen BK, Link JT, von Geldern T, Emery M, Wang J, Hickman B, Grynfarb M, Goos-Nilsson A, Carroll S.. (2003) An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist., 13 (14): [PMID:12824023] [10.1016/s0960-894x(03)00431-1] |
| 11. Morgan BP, Swick AG, Hargrove DM, LaFlamme JA, Moynihan MS, Carroll RS, Martin KA, Lee E, Decosta D, Bordner J.. (2002) Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists., 45 (12): [PMID:12036351] [10.1021/jm0105530] |
| 12. Hamann LG, Winn DT, Pooley CL, Tegley CM, West SJ, Farmer LJ, Zhi L, Edwards JP, Marschke KB, Mais DE, Goldman ME, Jones TK.. (1998) Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines., 8 (19): [PMID:9873612] [10.1016/s0960-894x(98)00482-x] |
| 13. Zhang P, Terefenko EA, Wrobel J, Zhang Z, Zhu Y, Cohen J, Marschke KB, Mais D.. (2001) Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones., 11 (20): [PMID:11591515] [10.1016/s0960-894x(01)00554-6] |
| 14. Edwards JP, Zhi L, Pooley CL, Tegley CM, West SJ, Wang MW, Gottardis MM, Pathirana C, Schrader WT, Jones TK.. (1998) Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists., 41 (15): [PMID:9667968] [10.1021/jm980190c] |
| 15. Pooley CL, Edwards JP, Goldman ME, Wang MW, Marschke KB, Crombie DL, Jones TK.. (1998) Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore., 41 (18): [PMID:9719599] [10.1021/jm9801915] |
| 16. Fensome A, Bender R, Cohen J, Collins MA, Mackner VA, Miller LL, Ullrich JW, Winneker R, Wrobel J, Zhang P, Zhang Z, Zhu Y.. (2002) New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles., 12 (23): [PMID:12419390] [10.1016/s0960-894x(02)00746-1] |
| 17. Zhang P, Terefenko EA, Fensome A, Wrobel J, Winneker R, Lundeen S, Marschke KB, Zhang Z.. (2002) 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists., 45 (20): [PMID:12238914] [10.1021/jm025555e] |
| 18. Fuhrmann U, Hess-Stumpp H, Cleve A, Neef G, Schwede W, Hoffmann J, Fritzemeier KH, Chwalisz K.. (2000) Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist., 43 (26): [PMID:11150172] [10.1021/jm001000c] |
| 19. Hamann LG, Higuchi RI, Zhi L, Edwards JP, Wang XN, Marschke KB, Kong JW, Farmer LJ, Jones TK.. (1998) Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines., 41 (4): [PMID:9484511] [10.1021/jm970699s] |
| 20. Zhang P, Terefenko EA, Fensome A, Zhang Z, Zhu Y, Cohen J, Winneker R, Wrobel J, Yardley J.. (2002) Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines., 12 (5): [PMID:11859003] [10.1016/s0960-894x(02)00025-2] |
| 21. Tu N, Link JT, Sorensen BK, Emery M, Grynfarb M, Goos-Nilsson A, Nguyen B.. (2004) Bile acid conjugates of a nonsteroidal glucocorticoid receptor modulator., 14 (16): [PMID:15261266] [10.1016/j.bmcl.2004.06.022] |
| 22. Link JT, Sorensen BK, Lai C, Wang J, Fung S, Deng D, Emery M, Carroll S, Grynfarb M, Goos-Nilsson A, Von Geldern T.. (2004) Synthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator-statin hybrids., 14 (16): [PMID:15261265] [10.1016/j.bmcl.2004.06.021] |
| 23. von Geldern TW, Tu N, Kym PR, Link JT, Jae HS, Lai C, Apelqvist T, Rhonnstad P, Hagberg L, Koehler K, Grynfarb M, Goos-Nilsson A, Sandberg J, Osterlund M, Barkhem T, Höglund M, Wang J, Fung S, Wilcox D, Nguyen P, Jakob C, Hutchins C, Färnegårdh M, Kauppi B, Ohman L, Jacobson PB.. (2004) Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes., 47 (17): [PMID:15293993] [10.1021/jm0400045] |
| 24. Muddana SS, Price AM, MacBride MM, Peterson BR.. (2004) 11beta-alkyl-Delta9-19-nortestosterone derivatives: high-affinity ligands and potent partial agonists of the androgen receptor., 47 (21): [PMID:15456242] [10.1021/jm0342515] |
| 25. Wang YH, Li Y, Li YH, Yang SL, Yang L.. (2005) Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism., 15 (18): [PMID:15990295] [10.1016/j.bmcl.2005.06.015] |
| 26. Link JT, Sorensen B, Patel J, Grynfarb M, Goos-Nilsson A, Wang J, Fung S, Wilcox D, Zinker B, Nguyen P, Hickman B, Schmidt JM, Swanson S, Tian Z, Reisch TJ, Rotert G, Du J, Lane B, von Geldern TW, Jacobson PB.. (2005) Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators., 48 (16): [PMID:16078847] [10.1021/jm050205o] |
| 27. Jones DG, Liang X, Stewart EL, Noe RA, Kallander LS, Madauss KP, Williams SP, Thompson SK, Gray DW, Hoekstra WJ.. (2005) Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonists., 15 (13): [PMID:15925510] [10.1016/j.bmcl.2005.05.001] |
| 28. Betageri R, Zhang Y, Zindell RM, Kuzmich D, Kirrane TM, Bentzien J, Cardozo M, Capolino AJ, Fadra TN, Nelson RM, Paw Z, Shih DT, Shih CK, Zuvela-Jelaska L, Nabozny G, Thomson DS.. (2005) Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand., 15 (21): [PMID:16112571] [10.1016/j.bmcl.2005.07.025] |
| 29. Wiethe RW, Stewart EL, Drewry DH, Gray DW, Mehbob A, Hoekstra WJ.. (2006) Array synthesis of progesterone receptor antagonists: 3-aryl-1,2-diazepines., 16 (14): [PMID:16678409] [10.1016/j.bmcl.2006.04.055] |
| 30. Barker M, Clackers M, Copley R, Demaine DA, Humphreys D, Inglis GG, Johnston MJ, Jones HT, Haase MV, House D, Loiseau R, Nisbet L, Pacquet F, Skone PA, Shanahan SE, Tape D, Vinader VM, Washington M, Uings I, Upton R, McLay IM, Macdonald SJ.. (2006) Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series., 49 (14): [PMID:16821781] [10.1021/jm060302x] |
| 31. Yeh VS, Kurukulasuriya R, Fung S, Monzon K, Chiou W, Wang J, Stolarik D, Imade H, Shapiro R, Knourek-Segel V, Bush E, Wilcox D, Nguyen PT, Brune M, Jacobson P, Link JT.. (2006) Discovery of orally active butyrolactam 11beta-HSD1 inhibitors., 16 (21): [PMID:16931002] [10.1016/j.bmcl.2006.08.034] |
| 32. Richards SJ, von Geldern TW, Jacobson P, Wilcox D, Nguyen P, Ohman L, Osterlund M, Gelius B, Grynfarb M, Goos-Nilsson A, Wang J, Fung S, Kalmanovich M.. (2006) Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists., 16 (23): [PMID:16987661] [10.1016/j.bmcl.2006.08.133] |
| 33. Backes BJ, Hamilton GL, Nguyen P, Wilcox D, Fung S, Wang J, Grynfarb M, Goos-Nilsson A, Jacobson PB, von Geldern TW.. (2007) Parallel strategies for the preparation and selection of liver-targeted glucocorticoid receptor antagonists., 17 (1): [PMID:17070047] [10.1016/j.bmcl.2006.10.001] |
| 34. Kang FA, Allan G, Guan J, Jain N, Linton O, Tannenbaum P, Xu J, Zhu P, Gunnet J, Chen X, Demarest K, Lundeen S, Sui Z.. (2007) Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists., 17 (4): [PMID:17169557] [10.1016/j.bmcl.2006.11.062] |
| 35. Kang FA, Guan J, Jain N, Allan G, Linton O, Tannenbaum P, Chen X, Xu J, Zhu P, Gunnet J, Demarest K, Lundeen S, Sui Z.. (2007) Parallel synthesis and SAR study of novel oxa-steroids as potent and selective progesterone receptor antagonists., 17 (9): [PMID:17317167] [10.1016/j.bmcl.2007.02.013] |
| 36. Hudson AR, Roach SL, Higuchi RI, Phillips DP, Bissonnette RP, Lamph WW, Yen J, Li Y, Adams ME, Valdez LJ, Vassar A, Cuervo C, Kallel EA, Gharbaoui CJ, Mais DE, Miner JN, Marschke KB, Rungta D, Negro-Vilar A, Zhi L.. (2007) Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma., 50 (19): [PMID:17705362] [10.1021/jm070370z] |
| 37. Clackers M, Coe DM, Demaine DA, Hardy GW, Humphreys D, Inglis GG, Johnston MJ, Jones HT, House D, Loiseau R, Minick DJ, Skone PA, Uings I, McLay IM, Macdonald SJ.. (2007) Non-steroidal glucocorticoid agonists: the discovery of aryl pyrazoles as A-ring mimetics., 17 (17): [PMID:17616395] [10.1016/j.bmcl.2007.06.066] |
| 38. Biggadike K, Boudjelal M, Clackers M, Coe DM, Demaine DA, Hardy GW, Humphreys D, Inglis GG, Johnston MJ, Jones HT, House D, Loiseau R, Needham D, Skone PA, Uings I, Veitch G, Weingarten GG, McLay IM, Macdonald SJ.. (2007) Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity., 50 (26): [PMID:18038970] [10.1021/jm070778w] |
| 39. Jiang W, Fiordeliso JJ, Allan G, Linton O, Tannenbaum P, Xu J, Zhu P, Gunnet J, Demarest K, Lundeen S, Sui Z.. (2007) Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist., 17 (5): [PMID:17258455] [10.1016/j.bmcl.2006.10.003] |
| 40. Wuest F, Kniess T, Bergmann R, Henry B, Pietzsch J.. (2007) Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptors., 17 (14): [PMID:17499506] [10.1016/j.bmcl.2007.04.094] |
| 41. Clark RD, Ray NC, Blaney P, Crackett PH, Hurley C, Williams K, Dyke HJ, Clark DE, Lockey PM, Devos R, Wong M, White A, Belanoff JK.. (2007) 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists., 17 (20): [PMID:17822897] [10.1016/j.bmcl.2007.07.055] |
| 42. Jin C, Manikumar G, Kepler JA, Cook CE, Allan GF, Kiddoe M, Bhattacharjee S, Linton O, Lundeen SG, Sui Z.. (2007) Synthesis and identification of novel 11beta-aryl-4',5'-dihydrospiro[estra-4,9-diene-17beta,4'-oxazole] analogs with dissociated antiprogesterone activities., 17 (21): [PMID:17855092] [10.1016/j.bmcl.2007.08.064] |
| 43. Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, Gulbins E.. (2008) Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model., 51 (2): [PMID:18027916] [10.1021/jm070524a] |
| 44. Clark RD, Ray NC, Williams K, Blaney P, Ward S, Crackett PH, Hurley C, Dyke HJ, Clark DE, Lockey P, Devos R, Wong M, Porres SS, Bright CP, Jenkins RE, Belanoff J.. (2008) 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity., 18 (4): [PMID:18226897] [10.1016/j.bmcl.2008.01.027] |
| 45. Fensome A, Adams WR, Adams AL, Berrodin TJ, Cohen J, Huselton C, Illenberger A, Kern JC, Hudak VA, Marella MA, Melenski EG, McComas CC, Mugford CA, Slayden OD, Yudt M, Zhang Z, Zhang P, Zhu Y, Winneker RC, Wrobel JE.. (2008) Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)., 51 (6): [PMID:18318463] [10.1021/jm701080t] |
| 46. Miner JN, Ardecky B, Benbatoul K, Griffiths K, Larson CJ, Mais DE, Marschke K, Rosen J, Vajda E, Zhi L, Negro-Vilar A.. (2007) Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile., 104 (49): [PMID:18032610] [10.1073/pnas.0705517104] |
| 47. Zsila F, Visy J, Mády G, Fitos I.. (2008) Selective plasma protein binding of antimalarial drugs to alpha1-acid glycoprotein., 16 (7): [PMID:18289858] [10.1016/j.bmc.2008.01.053] |
| 48. Kang FA, Chen X, Jain N, Allan G, Tannenbaum P, Lundeen S, Sui Z.. (2008) Insight from molecular modeling into different conformation and SAR of natural steroids and unnatural 7-oxa-steroids., 18 (13): [PMID:18539027] [10.1016/j.bmcl.2008.05.070] |
| 49. Hödl C, Raunegger K, Strommer R, Ecker GF, Kunert O, Sturm S, Seger C, Haslinger E, Steiner R, Strauss WS, Schramm HW.. (2009) Syntheses and antigestagenic activity of mifepristone derivatives., 52 (5): [PMID:19216549] [10.1021/jm800985z] |
| 50. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P.. (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)., 51 (11): [PMID:18457386] [10.1021/jm7015683] |
| 51. Kern JC, Terefenko EA, Fensome A, Unwalla R, Wrobel J, Cohen J, Zhu Y, Berrodin TJ, Yudt MR, Winneker RC, Zhang Z, Zhang P.. (2008) 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators., 18 (18): [PMID:18722119] [10.1016/j.bmcl.2008.08.015] |
| 52. Zhang P, Kern JC, Terefenko EA, Fensome A, Unwalla R, Zhang Z, Cohen J, Berrodin TJ, Yudt MR, Winneker RC, Wrobel J.. (2008) 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists., 16 (13): [PMID:18504132] [10.1016/j.bmc.2008.05.018] |
| 53. Robinson RP, Buckbinder L, Haugeto AI, McNiff PA, Millham ML, Reese MR, Schaefer JF, Abramov YA, Bordner J, Chantigny YA, Kleinman EF, Laird ER, Morgan BP, Murray JC, Salter ED, Wessel MD, Yocum SA.. (2009) Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration., 52 (6): [PMID:19239259] [10.1021/jm801512v] |
| 54. Jain N, Allan G, Linton O, Tannenbaum P, Chen X, Xu J, Zhu P, Gunnet J, Demarest K, Lundeen S, Murray W, Sui Z.. (2009) Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists., 19 (14): [PMID:19217285] [10.1016/j.bmcl.2009.01.095] |
| 55. Saha P, Hödl C, Strauss WS, Steiner R, Goessler W, Kunert O, Leitner A, Haslinger E, Schramm HW.. (2010) Synthesis, in vitro progesterone receptors affinity of gadolinium containing mifepristone conjugates and estimation of binding sites in human breast cancer cells., 18 (5): [PMID:20149664] [10.1016/j.bmc.2010.01.048] |
| 56. Roll DM, Barbieri LR, Bigelis R, McDonald LA, Arias DA, Chang LP, Singh MP, Luckman SW, Berrodin TJ, Yudt MR.. (2009) The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144., 72 (11): [PMID:19863083] [10.1021/np9004882] |
| 57. Onnis V, Kinsella GK, Carta G, Jagoe WN, Price T, Williams DC, Fayne D, Lloyd DG.. (2010) Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators., 53 (8): [PMID:20334371] [10.1021/jm901452y] |
| 58. Yates CM, Brown PJ, Stewart EL, Patten C, Austin RJ, Holt JA, Maglich JM, Angell DC, Sasse RZ, Taylor SJ, Uings IJ, Trump RP.. (2010) Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists., 53 (11): [PMID:20469868] [10.1021/jm100447c] |
| 59. Du Y, Li Q, Xiong B, Hui X, Wang X, Feng Y, Meng T, Hu D, Zhang D, Wang M, Shen J.. (2010) Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists., 18 (12): [PMID:20510622] [10.1016/j.bmc.2010.04.092] |
| 60. Kern JC, Terefenko E, Trybulski E, Berrodin TJ, Cohen J, Winneker RC, Yudt MR, Zhang Z, Zhu Y, Zhang P.. (2010) 1-Methyl-1H-pyrrole-2-carbonitrile containing tetrahydronaphthalene derivatives as non-steroidal progesterone receptor antagonists., 20 (16): [PMID:20638844] [10.1016/j.bmcl.2010.06.109] |
| 61. Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ.. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum., 5 (10): [PMID:19734910] [10.1038/nchembio.215] |
| 62. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
| 63. Yamaguchi H, Kamiya S, Uruma T, Osaki T, Taguchi H, Hanawa T, Fukuda M, Kawakami H, Goto H, Friedman H, Yamamoto Y.. (2008) Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone)., 52 (6): [PMID:18347111] [10.1128/aac.01416-07] |
| 64. PubChem BioAssay data set, |
| 65. PubChem BioAssay data set, |
| 66. PubChem BioAssay data set, |
| 67. PubChem BioAssay data set, |
| 68. PubChem BioAssay data set, |
| 69. Evans CA, Jolivette LJ, Nagilla R, Ward KW.. (2006) Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics., 34 (7): [PMID:16621936] [10.1124/dmd.105.006619] |
| 70. Richardson TI, Clarke CA, Yu KL, Yee YK, Bleisch TJ, Lopez JE, Jones SA, Hughes NE, Muehl BS, Lugar CW, Moore TL, Shetler PK, Zink RW, Osborne JJ, Montrose-Rafizadeh C, Patel N, Geiser AG, Galvin RJ, Dodge JA.. (2011) Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids., 2 (2): [PMID:24900294] [10.1021/ml100220b] |
| 71. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 72. Unpublished dataset, |
| 73. PubChem BioAssay data set, |
| 74. (2008) Casarett and Doull's Toxicology The Basic Science of Poisons, 7th edition, |
| 75. Fontana E, Dansette PM, Poli SM.. (2005) Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity., 6 (1): [PMID:16248836] [10.2174/138920005774330639] |
| 76. PubChem BioAssay data set, |
| 77. PubChem BioAssay data set, |
| 78. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
| 79. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 80. Abid Masood M, Farrant E, Morao I, Bazin M, Perez M, Bunnage ME, Fancy SA, Peakman T.. (2012) Lead diversification. Application to existing drug molecules: mifepristone 1 and antalarmin 8., 22 (1): [PMID:22104142] [10.1016/j.bmcl.2011.10.066] |
| 81. Jin C, Fix SE, Kepler JA, Cook CE.. (2012) Synthesis and antihormonal properties of novel 11β-benzoxazole-substituted steroids., 22 (4): [PMID:22260770] [10.1016/j.bmcl.2011.12.110] |
| 82. Lecureur V, Fardel O, Guillouzo A.. (1994) The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function., 355 (1): [PMID:7982498] [10.1016/0014-5793(94)01186-9] |
| 83. Geick A, Eichelbaum M, Burk O.. (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin., 276 (1): [PMID:11297522] [10.1074/jbc.m010173200] |
| 84. Payen L, Delugin L, Courtois A, Trinquart Y, Guillouzo A, Fardel O.. (1999) Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486., 258 (1): [PMID:10329417] [10.1006/bbrc.1999.0671] |
| 85. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 86. PubChem BioAssay data set, |
| 87. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.. (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions., 55 (10): [PMID:22541068] [10.1021/jm300212s] |
| 88. Unpublished dataset, |
| 89. Unpublished dataset, |
| 90. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 91. PubChem BioAssay data set, |
| 92. PubChem BioAssay data set, |
| 93. PubChem BioAssay data set, |
| 94. Ang W, Chen G, Xiong L, Chang Y, Pi W, Liu Y, Li C, Zheng J, Zhou L, Yang B, Deng Y, Yang S, Luo Y, Wei Y.. (2014) Synthesis and biological evaluation of novel naphthalene compounds as potential antidepressant agents., 82 [PMID:24915002] [10.1016/j.ejmech.2014.05.061] |
| 95. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
| 96. Lin HR.. (2014) Triterpenes from Alisma orientalis act as androgen receptor agonists, progesterone receptor antagonists, and glucocorticoid receptor antagonists., 24 (15): [PMID:24915879] [10.1016/j.bmcl.2014.05.039] |
| 97. de Ravel MR, Alameh G, Melikian M, Mahiout Z, Emptoz-Bonneton A, Matera EL, Lomberget T, Barret R, Rocheblave L, Walchshofer N, Beltran S, El Jawad L, Mappus E, Grenot C, Pugeat M, Dumontet C, Le Borgne M, Cuilleron CY.. (2015) Synthesis of new steroidal inhibitors of P-glycoprotein-mediated multidrug resistance and biological evaluation on K562/R7 erythroleukemia cells., 58 (4): [PMID:25634041] [10.1021/jm501676v] |
| 98. Lin HL, Zhang H, Medower C, Hollenberg PF, Johnson WW.. (2011) Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug., 39 (2): [PMID:21068193] [10.1124/dmd.110.034074] |
| 99. Eda M, Kuroda T, Kaneko S, Aoki Y, Yamashita M, Okumura C, Ikeda Y, Ohbora T, Sakaue M, Koyama N, Aritomo K.. (2015) Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists., 58 (12): [PMID:25978072] [10.1021/jm501758q] |
| 100. Luz JG, Carson MW, Condon B, Clawson D, Pustilnik A, Kohlman DT, Barr RJ, Bean JS, Dill MJ, Sindelar DK, Maletic M, Coghlan MJ.. (2015) Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site., 58 (16): [PMID:26218343] [10.1021/acs.jmedchem.5b00736] |
| 101. Hunt HJ, Belanoff JK, Golding E, Gourdet B, Phillips T, Swift D, Thomas J, Unitt JF, Walters I.. (2015) 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile., 25 (24): [PMID:26546213] [10.1016/j.bmcl.2015.10.097] |
| 102. WHO Anatomical Therapeutic Chemical Classification, |
| 103. British National Formulary (72nd edition), |
| 104. Yamada A, Kazui Y, Yoshioka H, Tanatani A, Mori S, Kagechika H, Fujii S.. (2016) Development of N-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists., 7 (12): [PMID:27994732] [10.1021/acsmedchemlett.6b00184] |
| 105. DrugMatrix, [10.6019/CHEMBL3885881] |
| 106. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101] [10.1093/toxsci/kft176] |
| 107. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 108. Hunt HJ, Belanoff JK, Walters I, Gourdet B, Thomas J, Barton N, Unitt J, Phillips T, Swift D, Eaton E.. (2017) Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist., 60 (8): [PMID:28368581] [10.1021/acs.jmedchem.7b00162] |
| 109. Nishiyama Y, Mori S, Makishima M, Fujii S, Kagechika H, Hashimoto Y, Ishikawa M.. (2018) Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton., 9 (7): [PMID:30034593] [10.1021/acsmedchemlett.8b00058] |
| 110. Rew Y, Du X, Eksterowicz J, Zhou H, Jahchan N, Zhu L, Yan X, Kawai H, McGee LR, Medina JC, Huang T, Chen C, Zavorotinskaya T, Sutimantanapi D, Waszczuk J, Jackson E, Huang E, Ye Q, Fantin VR, Sun D.. (2018) Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)., 61 (17): [PMID:30091920] [10.1021/acs.jmedchem.8b00743] |
| 111. Ripa L, Edman K, Dearman M, Edenro G, Hendrickx R, Ullah V, Chang HF, Lepistö M, Chapman D, Geschwindner S, Wissler L, Svanberg P, Lawitz K, Malmberg J, Nikitidis A, Olsson RI, Bird J, Llinas A, Hegelund-Myrbäck T, Berger M, Thorne P, Harrison R, Köhler C, Drmota T.. (2018) Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile., 61 (5): [PMID:29424542] [10.1021/acs.jmedchem.7b01690] |
| 112. Lin Y, Liu R, Zhao P, Ye J, Zheng Z, Huang J, Zhang Y, Gao Y, Chen H, Liu S, Zhou J, Chen C, Chen H.. (2018) Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer., 146 [PMID:29407962] [10.1016/j.ejmech.2018.01.056] |
| 113. Lee JH, Dean M, Austin JR, Burdette JE, Murphy BT.. (2018) Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling., 81 (9): [PMID:30199256] [10.1021/acs.jnatprod.8b00131] |
| 114. Christodoulou MS, Dapiaggi F, Ghiringhelli F, Pieraccini S, Sironi M, Lucafò M, Curci D, Decorti G, Stocco G, Chirumamilla CS, Vanden Berghe W, Balaguer P, Michel BY, Burger A, Beccalli EM, Passarella D, Martinet N.. (2018) Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor., 9 (4): [PMID:29670697] [10.1021/acsmedchemlett.7b00527] |
| 115. Mandal M, Mitra K, Grotz D, Lin X, Palamanda J, Kumari P, Buevich A, Caldwell JP, Chen X, Cox K, Favreau L, Hyde L, Kennedy ME, Kuvelkar R, Liu X, Mazzola RD, Parker E, Rindgen D, Sherer E, Wang H, Zhu Z, Stamford AW, Cumming JN.. (2018) Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety., 61 (23): [PMID:30388368] [10.1021/acs.jmedchem.8b01326] |
| 116. Unpublished dataset, |
| 117. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846] |
| 118. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 119. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 120. Wang X, Blackaby W, Allen V, Chan GKY, Chang JH, Chiang PC, Diène C, Drummond J, Do S, Fan E, Harstad EB, Hodges A, Hu H, Jia W, Kofie W, Kolesnikov A, Lyssikatos JP, Ly J, Matteucci M, Moffat JG, Munugalavadla V, Murray J, Nash D, Noland CL, Del Rosario G, Ross L, Rouse C, Sharpe A, Slaga D, Sun M, Tsui V, Wallweber H, Yu SF, Ebens AJ.. (2019) Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma., 62 (4): [PMID:30715878] [10.1021/acs.jmedchem.8b01857] |
| 121. Crane EA, Heydenreuter W, Beck KR, Strajhar P, Vomacka J, Smiesko M, Mons E, Barth L, Neuburger M, Vedani A, Odermatt A, Sieber SA, Gademann K.. (2019) Profiling withanolide A for therapeutic targets in neurodegenerative diseases., 27 (12): [PMID:30929949] [10.1016/j.bmc.2019.03.022] |
| 122. Du X, Eksterowicz J, Zhou H, Rew Y, Zhu L, Yan X, Medina JC, Huang T, Chen X, Sutimantanapi D, Jahchan N, Kong W, Sun J, Zavorotinskaya T, Ye Q, Fantin VR, Sun D.. (2019) Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)., 62 (14): [PMID:31274313] [10.1021/acs.jmedchem.9b00711] |
| 123. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 124. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 125. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 126. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 127. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection, [10.6019/CHEMBL4513141] |
| 128. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of MMV (CH) - Pandemic Response Box, [10.6019/CHEMBL4513161] |
| 129. Talele TT.. (2020) Acetylene Group, Friend or Foe in Medicinal Chemistry., 63 (11): [PMID:32031378] [10.1021/acs.jmedchem.9b01617] |
| 130. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 131. Wu M,Xie Y,Cui X,Huang C,Zhang R,He Y,Li X,Liu M,Cen S,Zhou J. (2019) Rational drug design for androgen receptor and glucocorticoids receptor dual antagonist., 166 [PMID:30711833] [10.1016/j.ejmech.2019.01.036] |
| 132. Song QQ,Rao Y,Tang GH,Sun ZH,Zhang JS,Huang ZS,Yin S. (2019) Tigliane Diterpenoids as a New Type of Antiadipogenic Agents Inhibit GRα-Dexras1 Axis in Adipocytes., 62 (4): [PMID:30707022] [10.1021/acs.jmedchem.8b01693] |
| 133. Qin J,Qu S,Zhu K,Cheng Y,Pan G,Jing W,Liu X,Sun X,Liu L. (2021) Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers., 32 [PMID:33461148] [10.1016/j.bmc.2021.116003] |
| 134. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 135. Li K, Diakite D, Austin J, Lee JH, Lantvit DD, Murphy BT, Burdette JE.. (2022) The Flavonoid Baicalein Negatively Regulates Progesterone Target Genes in the Uterus in Vivo., 85 (1.0): [PMID:34935393] [10.1021/acs.jnatprod.1c01008] |
| 136. Fu W, Zhang M, Liao J, Tang Q, Lei Y, Gong Z, Shan L, Duan M, Chai X, Pang J, Tang C, Wang X, Xu X, Li D, Sheng R, Hou T.. (2021) Discovery of a Novel Androgen Receptor Antagonist Manifesting Evidence to Disrupt the Dimerization of the Ligand-Binding Domain via Attenuating the Hydrogen-Bonding Network Between the Two Monomers., 64 (23.0): [PMID:34809430] [10.1021/acs.jmedchem.1c01287] |
| 137. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
